Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 5 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Rhabdoid Tumor 1 Rectal Neoplasms 1 Lung Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Chordoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Advanced Solid Malignancies 1 Advanced Liver Cancers 1

Interventions

Fluorouracil 14 pembrolizumab 13 Paclitaxel 13 Oxaliplatin 13 Leucovorin 10 Carboplatin 9 Radiotherapy 8 Capecitabine 8 Trastuzumab 7 Nivolumab 7 Drug Therapy 7 Cisplatin 7 Radiation 6 Esophagectomy 6 Taxes 5 Specimen Handling 5 Irinotecan 4 trastuzumab deruxtecan 3 tislelizumab 3 patritumab deruxtecan 3 Surgical Procedures, Operative 3 Radiotherapy, Intensity-Modulated 3 Immunotherapy 3 Blood Specimen Collection 3 zanidatamab 2 ulixertinib 2 trastuzumab biosimilar HLX02 2 relatlimab 2 durvalumab 2 atezolizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Esophageal Neoplasms × Tiragolumab × 90 days × Clear all

NCT04540211 2026-04-09

SKYSCRAPER-08

Hoffmann-La Roche

Phase 3 Completed

461 enrolled 24 charts

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡